Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid

Anemia in Myelodysplastic Syndromes Clinical Trial

Official title: Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is

• To evaluate the efficacy of association of Erythropoetin (Neorecormon) and ATRA in patients with low risk myelodysplastic syndromes

• To evaluate the tolerance of this treatment

Clinical Trial Description

n/a

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Anemia
• Anemia in Myelodysplastic Syndromes
• Myelodysplastic Syndromes
• Preleukemia
• Syndrome

• NCT number: NCT00437450
• Study type: Interventional
• Source: Groupe Francophone des Myelodysplasies
• Status: Active, not recruiting
• Phase: Phase 2
• Start date: October 2004
• Completion date: September 2005